Clinical Trial: A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined With Concurrent Chemoradiotherapy for the Treatment of Locally Advanced Cervical Cancer

U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07168200) titled 'A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined With Concurrent Chemoradiotherapy for the Treatment of Locally Advanced Cervical Cancer' on Sept. 04.

Brief Summary: This study aims to evaluate the efficacy of Adebrelimab plus concurrent chemoradiotherapy compared with placebo plus concurrent chemoradiotherapy for the treatment of locally advanced cervical cancer by evaluating progression-free survival (PFS).

Study Start Date: Sept., 2025

Study Type: INTERVENTIONAL

Condition: Advanced Cervical Cancer

Intervention: DRUG: SHR-1316 Injection

SHR-1316 injection.

DRUG: ...